Filing Details
- Accession Number:
- 0001628280-22-002171
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-10 09:01:18
- Reporting Period:
- 2022-02-09
- Accepted Time:
- 2022-02-10 09:01:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1672688 | Absci Corp | ABSI | Services-Commercial Physical & Biological Research (8731) | 453931977 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1872400 | Sarah Korman | C/O Absci Corporation 18105 Se Mill Plain Blvd. Vancouver WA 98683 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-02-09 | 4,250 | $7.96 | 14,250 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price of the shares purchased ranging from $7.95 to $8.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote.